301
|
|
|
Myocyte enhancer factor 2D |
- |
|
302
|
|
|
MEFV innate immunity regulator, pyrin |
FMF, MEF, PAAND, TRIM20 |
Ankylosing spondylitis, Psoriatic arthritis, Asthma, Autoinflammatory syndrome, Behcet disease, Congenital heart defects, Henoch schoenlein purpura, Intermittent hydrarthrosis, Lung disease, Systemic lupus erythematosus, Neuronal ceroid lipofuscinosis, Peripheral neuropathy, Sweet syndrome, Urticaria |
303
|
|
|
Multiple EGF like domains 10 |
CMYO10A, CMYO10B, CMYP10A, CMYP10B, EMARDD, SR-F3 |
|
304
|
|
|
Multiple EGF like domains 11 |
- |
|
305
|
|
|
Multiple EGF like domains 6 |
EGFL3 |
|
306
|
|
|
Multiple EGF like domains 8 |
C19orf49, CRPT2, EGFL4, SBP1 |
|
307
|
|
|
Multiple EGF like domains 9 |
EGFL5 |
|
308
|
|
|
Meiotic double-stranded break formation protein 1 |
HYDM3, SPATA38 |
|
309
|
|
|
Meiotic double-stranded break formation protein 4 |
- |
Alzheimer disease, Eczema, Atrial fibrillation, Benign prostatic hyperplasia, Breast cancer, Cardiovascular disease, Cervical polyp, Color vision deficiency, Coronary artery disease, Female infertility, Heart failure, Hypertension, Metabolic syndrome, Nonalcoholic fatty liver disease, Scoliosis, Sjogren syndrome, Diabetes mellitus type 2View all (2 more) |
310
|
|
|
Meiotic kinetochore factor |
SPO13 |
|